 "API Holdings' proposed 100% acquisition of Medlife gets CCI's approval")
The Competition Commission of India (CCI) on Wednesday approved the proposed combination of Medlife and API Holdings.
The deal pertains to the proposed acquisition of 100 per cent equity shares of Medlife by API Holdings. Medlife shareholders are to get up to 19.59 per cent equity share capital of API Holdings.
Medlife is a healthcare company is primarily engaged in wholesale and distribution of drugs, while API Holdings is the parent entity of API Holdings group.
"CCI approves proposed combination of Medlife & API Holdings," the fair trade regulator said in a tweet. API Holdings is the parent of online pharma entity PharmEasy.
In June, a composite scheme of amalgamation filed by API Holdings had been approved by the National Company Law Tribunal (NCLT).
The rehgulator had on Tuesday approved the proposed merger of e-pharmacy companies Medlife and PharmEasy, a month after Medlife made a formal filing to merge with the Temasek-backed company.
Medlife, a Patna-based company, was valued at $375 million as of January 31, 2020.
(More details awaited)
(More details awaited)
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%